Home
About Us
Who we are
Founders and Chairs
Individual Members
Emeritus Members
Corporate and Research Members
Cambridge Angels Team
Infographic
Entrepreneurs
Why Cambridge Angels?
Is Angel Investing right for you?
Investment Criteria
Application Process
Apply
Angels
Membership Information
Member portal
Angel Interviews
Portfolio
Current Portfolio
Exits
Cambridge Angels Founded Companies
Portfolio facts
Portfolio Interviews
Apply to Cambridge Angels
News
Portfolio News
Ecosystem News

Welcome to the Cambridge Angels

Home
About Us
Who we are
Founders and Chairs
Individual Members
Emeritus Members
Corporate and Research Members
Cambridge Angels Team
Infographic
Entrepreneurs
Why Cambridge Angels?
Is Angel Investing right for you?
Investment Criteria
Application Process
Apply
Angels
Membership Information
Member portal
Angel Interviews
Portfolio
Current Portfolio
Exits
Cambridge Angels Founded Companies
Portfolio facts
Portfolio Interviews
Apply to Cambridge Angels
News
Portfolio News
Ecosystem News
NK:IO progresses ovarian cancer natural killer therapy
4 October 2024
Guest User
NK:IO progresses ovarian cancer natural killer therapy
Guest User
4 October 2024

NK:IO progresses ovarian cancer natural killer therapy

Guest User
4 October 2024

Source:https://www.ddw-online.com/nkio-progresses-ovarian-cancer-natural-killer-therapy-31821-202410/

Newer PostQkine wins ‘Scale-up of the Year’ at the 2024 Cambridge Independent Business Awards
Older Post‘We’re building the UK’s first $1tn company’ — Amazon Alexa creator’s new startup
LI-In-Bug_small.png
Back to Top
Privacy
info@cambridgeangels.net